Metraipolis › archive › dc_e02583ae9000
Safety of sinopharm COVID-19 vaccine in children and adolescents aged 5 to 18 years: a cohort event monitoring study — Europe PMC PMID:41316104
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41316104
- DOI
- 10.1186/s12889-[numero omesso]-1
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-06T08:13:09.373Z
- SHA-256 of the archived text
1fca0aac919a8adad18cf1bbbff5128836cbc107a21257b718f9a715b143cd87- Stable URL of this page
https://metraipolis.com/documento/dc_e02583ae9000
How to cite
Safety of sinopharm COVID-19 vaccine in children and adolescents aged 5 to 18 years: a cohort event monitoring study — Europe PMC PMID:41316104 — Europe PMC (en), https://europepmc.org/article/MED/41316104 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e02583ae9000 (Metraipolis archive dc_e02583ae9000, sha256 1fca0aac919a8adad18cf1bbbff5128836cbc107a21257b718f9a715b143cd87)
BibTeX
@misc{dce02583ae9000,
title = {Safety of sinopharm COVID-19 vaccine in children and adolescents aged 5 to 18 years: a cohort event monitoring study — Europe PMC PMID:41316104},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41316104},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e02583ae9000; sha256 1fca0aac919a8adad18cf1bbbff5128836cbc107a21257b718f9a715b143cd87},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41316104. Agents can read the archived copy with the MCP tool read_document.